Trial site
UCSF Medical Center-Mount Zion
- 22running trials
- 19closed trials
The trials here
What the 42 trials at this site are about, from their registry records.
- Conditions
- Head and neck cancer6 trials
- Lung cancer6 trials
- Prostate cancer6 trials
- Childhood cancers4 trials
- Metastatic breast cancer3 trials
- Ovarian cancer3 trials
- Pancreatic cancer3 trials
- Colorectal cancer2 trials
- Kidney cancer2 trials
- Melanoma2 trials
- Multiple myeloma2 trials
- Bladder cancer1 trial
- and 10 more
- Phase
- Phase 316 trials
- Phase 214 trials
- Phase 13 trials
- Phase 1/23 trials
- Phase 2/33 trials
- Early phase 11 trial
- Status
- Active, not recruiting21 trials
- Completed18 trials
- Recruiting1 trial
- Suspended1 trial
- Terminated1 trial
- Lead sponsor
- National Cancer Institute (NCI)22 trials
- NRG Oncology4 trials
- Radiation Therapy Oncology Group4 trials
- SWOG Cancer Research Network3 trials
- ECOG-ACRIN Cancer Research Group2 trials
- and 7 more
Running trials
Active, not recruiting
Recruiting
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Active, not recruiting
Active, not recruiting
Testing AZD1775 in Advanced Solid Tumors That Have a Mutation Called SETD2
Active, not recruiting
Multicenter Randomized Trial of 68Ga-PSMA-11 PET/CT Based SRT After Radical Prostatectomy
Active, not recruiting
Active, not recruiting
Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors
Active, not recruiting
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Active, not recruiting
Active, not recruiting
Active, not recruiting
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Active, not recruiting
Active, not recruiting
Active, not recruiting
Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas
Active, not recruiting
Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Pancreatic cancer1 recruiting
Closed trials
Completed
Completed
Terminated
Completed
Completed
Completed
Vemurafenib in Children With Recurrent/Refractory BRAF Gene V600E (BRAFV600E)-Mutant Gliomas
Completed
Completed
Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV Cancer
Completed
Completed
S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer
Completed
Completed
S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Completed
Completed
Completed
Completed
Completed
Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026